A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...

Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that targets the root cause of how the disease exists and spreads. Arizona ...

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the ...

An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial. The drug, daraxonrasib, targets the gene mutation ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy.

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as ...

A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, ...

A virus has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially ...

Luisa Escobar-Hoyos envisions a world where a pancreatic cancer diagnosis is no longer a death sentence. “Every time I tell people I work on pancreatic cancer, people are like, ‘That’s a really bad ...